Status:
COMPLETED
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Lead Sponsor:
Organon and Co
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.
Eligibility Criteria
Inclusion
- Six month history of migraine; attacks typically mild when they begin with 1-4 migraine attacks per month.
Exclusion
- Heart disease
- High blood pressure
Key Trial Info
Start Date :
October 21 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2005
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00095004
Start Date
October 21 2004
End Date
April 4 2005
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.